Arrowhead Pharmaceuticals Inc. buy Piper Sandler
Start price
23.07.26
/
50%
€77.36
Target price
23.07.27
€110.25
Performance (%)
-2.69%
Price
24.07.26
€75.28
Summary
This prediction is currently active. With a performance of -2.69%, the BUY prediction for Arrowhead Pharmaceuticals Inc. by Piper_Sandler is down slightly. This prediction currently runs until 23.07.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Arrowhead Pharmaceuticals Inc. | -2.69% |
| iShares Core DAX® | 0.855% |
| iShares Nasdaq 100 | -0.989% |
| iShares Nikkei 225® | -1.781% |
| iShares S&P 500 | 0.057% |
Comments by Piper_Sandler for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (ARWR) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $126.00 price target on the stock, up from $110.00.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€58.38
13.01.26
13.01.26
€94.35
13.01.27
13.01.27
28.95%
24.07.26
24.07.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€55.98
17.12.25
17.12.25
€85.13
17.12.26
17.12.26
34.48%
24.07.26
24.07.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.14
19.11.25
19.11.25
€60.47
19.11.26
19.11.26
120.50%
24.07.26
24.07.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.00
27.11.24
27.11.24
€42.54
27.11.25
27.11.25
100.00%
28.11.25
28.11.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.42
08.10.24
08.10.24
€56.53
08.10.25
08.10.25
91.78%
09.10.25
09.10.25